The window of opportunity for the maximal beneficial effect of HT on total mortality and CHD appears to be when HT is initiated within 6 years of menopause and/or before age 60, and continued for 5 years or more. The absolute risks associated with HT are low and even rarer (<1 additional event/1,000 women) in women younger than age 60 or within 5 years after menopause when initiating HT. The risks associated with ET alone are negligible. (free signup required to read)
by
surmeno
2008-02-29 19:46
cardiovascular disease
·
risks
·
hrts
·
menopause